Biotech Growth Trust (The) (BIOG)

Sector:

Investment Firms

Index:

FTSE Small Cap

937.00p
   
  • Change Today:
      11.00p
  • 52 Week High: 1,010.00
  • 52 Week Low: 718.00
  • Currency: UK Pounds
  • Shares Issued: 33.42m
  • Volume: 30,088
  • Market Cap: £313.12m
  • RiskGrade: 135

Shire Chairman sells shares following 'excellent' 2013 results

Date: Friday 21 Feb 2014

LONDON (ShareCast) - Shire's Chairman, Matthew Emmens, has sold 36,100 shares in the biopharmaceutical company following its ‘excellent’ results for 2013.

Emmens disposed of the shares at 3,314.85p each for a total of just under £1.2m shares.

After a pick-up in earnings growth in the fourth quarter, the group beat forecasts for the full-year. Revenues during the quarter rose 12% to $1.33bn, helped by strong growth in product sales of Vyvanse, Lialda/Mezavant, Vpriv and Firazyr.

Revenues in 2013 rose by 12% to $4.76bn, while the company raised its full-year dividend by 15% to 19.93 cents. Shire also said that it expects to deliver a similar level of earnings growth in 2014.

Mark Bristow, the long-time Chief Executive of Randgold Resources, has sold off 40,000 shares in the FTSE 100-listed precious metals miner.

The 4,716p-a-share sale saw Bristow make the most of the huge surge in the company's share price during the past five weeks, during which time it has soared around 1,200p after the group predicted its output would rise over the next five years.

Bristow hailed 2013 as one of the company's best ever years as it reported record gold production, up 15% on the previous year.

The miner predicted that 2014 would see a production increase of between 25% and 30%, largely driven by the progress being made at its Loulo-Gounkoto and Kibali sites.

The £1.9m deal reduced the director's holding to 714,963 shares, equal to 0.77% of the group's issued share capital.


Top Director Buys

BAE Systems (BA.)
Director name: Mr Chris Grigg
Amount purchased: 24,555 @ 406.38p
Value: £99,787

Wood Group (John) (WG.)
Director name: Mr Jeremy Wilson
Amount purchased: 10,000 @ 743.00p
Value: £74,300

Terra Capital (TCA)
Director name: Mr Filip Montfort
Amount purchased: 65,000 @ $0.77
Value: $50,050

Biotech Growth Trust (The) (BIOG)
Director name: Mr Peter Keen
Amount purchased: 5,000 @ 514.29p
Value: £25,714

Informa (INF)
Director name: Mr Derek Mapp
Amount purchased: 4,438 @ 529.76p
Value: £23,511


Top Director Sells

Randgold Resources Ltd. (RRS)
Director name: Dr D Mark Bristow
Amount sold: 40,000 @ 4,716.00p
Value: £1,886,400

Shire Plc (SHP)
Director name: Mr Matthew Emmens
Amount sold: 36,100 @ 3,314.85p
Value: £1,196,661

Allocate Software (ALL)
Director name: Mr Ian Bowles
Amount sold: 476,968 @ 116.00p
Value: £553,283

Informa (INF)
Director name: Mr Derek Mapp
Amount sold: 4,438 @ 529.68p
Value: £23,507

Morgan Advanced Materials (MGAM)
Director name: Mr Paul Andrew Boulton
Amount sold: 7,000 @ 327.62p
Value: £22,933

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

BIOG Market Data

Currency UK Pounds
Share Price 937.00p
Change Today 11.00p
% Change 1.19 %
52 Week High 1,010.00
52 Week Low 718.00
Volume 30,088
Shares Issued 33.42m
Market Cap £313.12m
RiskGrade 135

BIOG Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
31.62% above the market average31.62% above the market average31.62% above the market average31.62% above the market average31.62% above the market average
20.4% below the sector average20.4% below the sector average20.4% below the sector average20.4% below the sector average20.4% below the sector average
Price Trend
77.73% above the market average77.73% above the market average77.73% above the market average77.73% above the market average77.73% above the market average
86.83% above the sector average86.83% above the sector average86.83% above the sector average86.83% above the sector average86.83% above the sector average
Income Not Available
Growth
57.59% below the market average57.59% below the market average57.59% below the market average57.59% below the market average57.59% below the market average
45.93% below the sector average45.93% below the sector average45.93% below the sector average45.93% below the sector average45.93% below the sector average

BIOG Dividends

No dividends found

Trades for 26-Apr-2024

Time Volume / Share Price
16:35 6,778 @ 937.00p
16:35 19 @ 937.00p
16:35 3 @ 937.00p
16:35 294 @ 937.00p
16:35 67 @ 937.00p

Top of Page